Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $359.99B|Employees: 131.9K
Johnson & Johnson is a healthcare company that manufactures and sells a wide range of products, including pharmaceuticals, medical devices, and consumer healthcare products. Its primary revenue streams are derived from sales to retailers, wholesalers, distributors, hospitals, and healthcare professionals. The company holds a leading market position in many of its product categories due to its strong brand recognition, extensive research and development capabilities, and global reach.
While specific figures are not explicitly stated in the provided excerpt, the document mentions that worldwide sales increased by 3.3% in the first six months of 2024 compared to the same period in 2023. Further analysis of the full 10-Q would be needed to confirm a 20% YoY increase and provide more detailed information.
The provided excerpt does not contain information on profit margins. A complete review of the 10-Q is needed to assess profit margin changes.
The excerpt mentions cash and cash equivalents figures but lacks details on cash flow from operations. A complete review of the 10-Q is needed for a comprehensive cash flow analysis.